It is the European Commission that intends to decide in “a few days” whether the validity of EU vaccine certificates should be linked to booster doses after a certain period of time.
The green certificate, conditioned by dose 3?
Thus, Greek Prime Minister Kyriakos Mitsotakis said that the EU’s green coronavirus certificate should be conditioned by booster doses after six months, “to avoid any crack in the wall of immunity that has already been built on our continent.”
Mitsotakis also said he would propose such a suggestion to European Commission President Ursula von der Leyen.
French President Emmanuel Macron also said last week that the green certificate would be linked to booster doses for those eligible to receive them.
Asked about these comments at a press conference yesterday, a Commission spokesman said that “there is currently no validity period for vaccination certificates”, but that “this is part of the problems on which we intend to address in the next two days ”.
“Give us a few days and then we will provide more clarity from us on the validity of vaccine certificates… and the issue of recalls,” he said, adding that the Commission would make a proposal to amend the rules. EU which must then be discussed and adopted by the member countries as well.
It should be mentioned that the presentation of a valid vaccine certificate has become mandatory in most EU countries in order to enter bars, restaurants, sports competitions or nightclubs, but also for travel.
Dose 3 of Cfid vaccine from Pfizer, 95% efficacy against symptomatic forms of the disease
According to a new study, a third dose of Pfizer’s covid vaccine is 95.6% effective against symptomatic forms of the disease.
It should be noted that the phase 3 clinical study, conducted among “10,000 people over the age of 16, shows a relative efficacy of 95.6% and a favorable safety profile,” a statement said.
“These are the first efficacy results of a randomized study for a booster with the COVID-19 vaccine,” the two companies said.
The study was conducted while the Delta variant of coronavirus was the main strain that circulated during this period.
“These results demonstrate once again the usefulness of booster doses in our efforts to protect the population against this disease,” Pfizer CEO Albert Bourla was quoted as saying.